Currently out of the existing stock ratings of Glenn Novarro, 56 are a BUY (84.85%), 10 are a HOLD (15.15%).

Glenn Novarro

Work Performance Price Targets & Ratings Chart

Analyst Glenn Novarro, carries an average stock price target met ratio of 97.73% that have a potential upside of 25.36% achieved within 320 days. Previously, Glenn Novarro worked at RBC.

Glenn Novarro’s has documented 113 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HOLX, Hologic at 01-Aug-2019.

Wall Street Analyst Glenn Novarro

Analyst best performing recommendations are on EW (EDWARDS LIFESCIENCES CORP).
The best stock recommendation documented was for BSX (BOSTON SCIENTIFIC CORP) at 4/12/2016. The price target of $22 was fulfilled within 20 days with a profit of $2.69 (13.93%) receiving and performance score of 6.97.

Average potential price target upside

of $35.92 (34.89%) on JNJ (JOHNSON & JOHNSON).
of $25.38 (25.88%) on ZBH (ZIMMER BIOMET HOLDINGS).
of $25.13 (30.87%) on MDT (MEDTRONIC PLC).

BAX Baxter International BSX Boston Scientific Corp ELGX Endologix EW Edwards Lifesciences Corp HOLX Hologic JNJ Johnson & Johnson MDT Medtronic PLC ABT Abbott Laboratories ZBH Zimmer Biomet Holdings NUVA NuVasive SYK Stryker

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Matt Miksic (BARCLAYS)